CTDSPL2
CTD small phosphatase-like protein 2
Also known as: CTSL2_HUMAN, FLJ10523, HSPC129
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q05D32
- Gene
- CTDSPL2
- Ensembl
- ENSG00000137770
- Chromosome
- 15
- Canonical length
- 466 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables RNA polymerase II CTD heptapeptide repeat phosphatase activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within negative regulation of BMP signaling pathway; positive regulation of protein export from nucleus; and protein dephosphorylation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
466 residues, UniProt reviewed canonical sequence.
>Q05D32|CTDSPL2
1 MRLRTRKASQ QSNQIQTQRT ARAKRKYSEV DDSLPSGGEK PSKNETGLLS SIKKFIKGST
61 PKEERENPSK RSRIERDIDN NLITSTPRAG EKPNKQISRV RRKSQVNGEA GSYEMTNQHV
121 KQNGKLEDNP SSGSPPRTTL LGTIFSPVFN FFSPANKNGT SGSDSPGQAV EAEEIVKQLD
181 MEQVDEITTS TTTSTNGAAY SNQAVQVRPS LNNGLEEAEE TVNRDIPPLT APVTPDSGYS
241 SAHAEATYEE DWEVFDPYYF IKHVPPLTEE QLNRKPALPL KTRSTPEFSL VLDLDETLVH
301 CSLNELEDAA LTFPVLFQDV IYQVYVRLRP FFREFLERMS QMYEIILFTA SKKVYADKLL
361 NILDPKKQLV RHRLFREHCV CVQGNYIKDL NILGRDLSKT IIIDNSPQAF AYQLSNGIPI
421 ESWFMDKNDN ELLKLIPFLE KLVELNEDVR PHIRDRFRLH DLLPPDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTDSPL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- thymus: 24 nTPM
- testis: 20 nTPM
- bone marrow: 19 nTPM
- lymph node: 18 nTPM
- tonsil: 18 nTPM
- ovary: 17 nTPM
Single-cell type
- late spermatids: 234 nCPM
- early spermatids: 219 nCPM
- sertoli cells: 162 nCPM
- myonuclei: 157 nCPM
- fibro-adipogenic progenitors: 155 nCPM
- monocyte progenitors: 139 nCPM
Immune cell
- NK-cell: 16 nTPM
- T-reg: 15 nTPM
- myeloid DC: 14 nTPM
- naive CD8 T-cell: 12 nTPM
- intermediate monocyte: 11 nTPM
- classical monocyte: 11 nTPM
Brain region
- cerebellum: 36 nTPM
- white matter: 21 nTPM
- cerebral cortex: 20 nTPM
- hypothalamus: 18 nTPM
- basal ganglia: 17 nTPM
- medulla oblongata: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.2
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone development
- cartilage development
- embryonic skeletal system development
- growth plate cartilage chondrocyte growth
- negative regulation of BMP signaling pathway
- positive regulation of gluconeogenesis
- positive regulation of protein export from nucleus
- protein export from nucleus
Molecular functions
- phosphoprotein phosphatase activity
- protein serine/threonine phosphatase activity
- RNA polymerase II CTD heptapeptide repeat phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTDSPL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTDSPL2 as an antibody target. Whether an autoantibody or antibody against CTDSPL2 could matter depends on whether native CTDSPL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTDSPL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTDSPL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...